Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Healthcare >

AtriCure Inc. (ATRC)

Add ATRC Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/30/2017 11:31:53 AM - Followers: 1 - Board type: Free - Posts Today: 0

AtriCure, Inc., is a medical device company. The Company develops, manufactures and sells cardiac surgical ablation systems designed to create lesions, or scars, in cardiac, or heart, tissue and devices for the exclusion of the left atrial appendage. The Company has two primary product lines for the ablation of cardiac tissue. Its primary product line, which accounts for a majority of its revenues, is Isolator Synergy bipolar ablation clamp system (Isolator system) and related radiofrequency ablation devices. It also offers a cryoablation product line, which features reusable and disposable cryoablation devices. In addition, it offers the AtriClip Gillinov-Cosgrove Left Atrial Appendage System, or AtriClip system, which is designed to exclude the left atrial appendage.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ATRC News: AtriCure to Present at the Stifel Healthcare Conference 10/20/2017 08:00:00 AM
ATRC News: Mike Hooven, Founder of AtriCure (NASDAQ: ATRC) and Enable Injections, Joins Genetesis Board of Directors 10/11/2017 11:11:00 AM
ATRC News: Schedule 13g 10/10/2017 10:52:25 AM
ATRC News: AtriCure to Announce Third Quarter 2017 Financial Results 10/10/2017 08:00:00 AM
ATRC News: Statement of Changes in Beneficial Ownership (4) 09/18/2017 04:21:09 PM